SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 15.93% to Rs. 9702.93 millions for the quarter ended June 2024 as compared to Rs. 8369.58 millions during the corresponding quarter last year.A humble growth in net profit of 11.66% reported in the quarter ended June 2024 to Rs. 404.46  millions from Rs. 362.22 millions.Operating Profit saw a handsome growth to 1476.94 millions from 1328.90 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202406 202306 % Var
Sales 9702.93 8369.58 15.93 9702.93 8369.58 15.93 9702.93 8369.58 15.93
Other Income 325.06 214.22 51.74 325.06 214.22 51.74 325.06 214.22 51.74
PBIDT 1476.94 1328.90 11.14 1476.94 1328.90 11.14 1476.94 1328.90 11.14
Interest 375.67 387.22 -2.98 375.67 387.22 -2.98 375.67 387.22 -2.98
PBDT 1101.27 941.68 16.95 1101.27 941.68 16.95 1101.27 941.68 16.95
Depreciation 550.79 462.95 18.97 550.79 462.95 18.97 550.79 462.95 18.97
PBT 550.48 478.73 14.99 550.48 478.73 14.99 550.48 478.73 14.99
TAX 146.02 116.51 25.33 146.02 116.51 25.33 146.02 116.51 25.33
Deferred Tax 16.89 -1.56 -1182.69 16.89 -1.56 -1182.69 16.89 -1.56 -1182.69
PAT 404.46 362.22 11.66 404.46 362.22 11.66 404.46 362.22 11.66
Equity 1811.52 1808.52 0.17 1811.52 1808.52 0.17 1811.52 1808.52 0.17
PBIDTM(%) 15.22 15.88 -4.13 15.22 15.88 -4.13 15.22 15.88 -4.13

Emcure Pharma Share Price

1670.10 -8.40 (-0.50%)
12-May-2026 14:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1859.10
Dr. Reddys Lab 1277.70
Cipla 1303.00
Zydus Lifesciences 935.40
Lupin 2265.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×